172 related articles for article (PubMed ID: 38491080)
1. Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study.
Guan Z; Liu J; Zheng L
Sci Rep; 2024 Mar; 14(1):6304. PubMed ID: 38491080
[TBL] [Abstract][Full Text] [Related]
2. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
Alsner J; Sørensen SB; Overgaard J
Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447
[TBL] [Abstract][Full Text] [Related]
3. Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient.
Sun Y; Yang J; Cai H; Liu J; Liu Y; Luo J; Zhou H
J Oral Pathol Med; 2022 Aug; 51(7):611-619. PubMed ID: 35708285
[TBL] [Abstract][Full Text] [Related]
4. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.
Alsner J; Høyer M; Sørensen SB; Overgaard J
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):519-25. PubMed ID: 11173149
[TBL] [Abstract][Full Text] [Related]
5. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
[TBL] [Abstract][Full Text] [Related]
6. PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma.
Huang CS; Hsieh MS; Yadav VK; Wu YC; Liu SC; Yeh CT; Huang MS
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139175
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
8. [Effect of
Yao YF; Liu W; Zhou ML; Qiu TL; Wang K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):457-465. PubMed ID: 35642155
[TBL] [Abstract][Full Text] [Related]
9. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
13. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
14. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.
Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z
Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534
[TBL] [Abstract][Full Text] [Related]
15. Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Ye MH; Huang XY; Li CJ; Wu QJ; Liu F
Chin J Dent Res; 2023 Dec; 26(4):235-248. PubMed ID: 38126369
[TBL] [Abstract][Full Text] [Related]
16. Conjoint analysis of OPRPN and SMR3A protein expression as potential predictive biomarkers for head and neck squamous cell carcinoma after radiotherapy.
Rong C; Grünow J; Thierauf J; Lucena-Porcel C; Major G; Holzinger D; Dyckhoff G; Kern J; Lammert A; Scherl C; Rotter N; Plinkert PK; Affolter A
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856431
[TBL] [Abstract][Full Text] [Related]
17. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
18. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
[TBL] [Abstract][Full Text] [Related]
19. miR-211-3p enhances induction chemotherapy insensitivity by upregulating CSF2/CCL20/TNF signaling in hypopharyngeal squamous cell carcinoma.
Wang L; Wang R; Huang T; Yang Y; Feng L; Fang J
Mol Biol Rep; 2022 Jul; 49(7):6103-6112. PubMed ID: 35397087
[TBL] [Abstract][Full Text] [Related]
20. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
PeerJ; 2023; 11():e16237. PubMed ID: 37842043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
